 | • レポートコード：MRC2Q12-19037 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ファモチジン注射のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ファモチジン注射のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ファモチジン注射の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ファモチジン注射のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのファモチジン注射の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のファモチジン注射の売上および2028年までの予測に焦点を当てています。 ファモチジン注射のグローバル主要企業には、Rakshit Drugs、Gauri Fine Chemicals、PAT IMPEX、Hainan Shuangcheng Pharmaceuticals、Hikma Pharmaceuticals、Baxter Healthcare、Athenex、Mylan Pharmaceuticals、Actiza Pharmaceutical、Omega Labsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ファモチジン注射市場は、タイプとアプリケーションによって区分されます。世界のファモチジン注射市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 10mg/mL、20mg/mL 【アプリケーション別セグメント】 病院、診療所 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ファモチジン注射製品概要 - タイプ別市場（10mg/mL、20mg/mL） - アプリケーション別市場（病院、診療所） - 調査の目的 ・エグゼクティブサマリー - 世界のファモチジン注射販売量予測2017-2028 - 世界のファモチジン注射売上予測2017-2028 - ファモチジン注射の地域別販売量 - ファモチジン注射の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ファモチジン注射販売量 - 主要メーカー別ファモチジン注射売上 - 主要メーカー別ファモチジン注射価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（10mg/mL、20mg/mL） - ファモチジン注射のタイプ別販売量 - ファモチジン注射のタイプ別売上 - ファモチジン注射のタイプ別価格 ・アプリケーション別市場規模（病院、診療所） - ファモチジン注射のアプリケーション別販売量 - ファモチジン注射のアプリケーション別売上 - ファモチジン注射のアプリケーション別価格 ・北米市場 - 北米のファモチジン注射市場規模（タイプ別、アプリケーション別） - 主要国別のファモチジン注射市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのファモチジン注射市場規模（タイプ別、アプリケーション別） - 主要国別のファモチジン注射市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のファモチジン注射市場規模（タイプ別、アプリケーション別） - 主要国別のファモチジン注射市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のファモチジン注射市場規模（タイプ別、アプリケーション別） - 主要国別のファモチジン注射市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのファモチジン注射市場規模（タイプ別、アプリケーション別） - 主要国別のファモチジン注射市場規模（トルコ、サウジアラビア） ・企業情報 Rakshit Drugs、Gauri Fine Chemicals、PAT IMPEX、Hainan Shuangcheng Pharmaceuticals、Hikma Pharmaceuticals、Baxter Healthcare、Athenex、Mylan Pharmaceuticals、Actiza Pharmaceutical、Omega Labs ・産業チェーン及び販売チャネル分析 - ファモチジン注射の産業チェーン分析 - ファモチジン注射の原材料 - ファモチジン注射の生産プロセス - ファモチジン注射の販売及びマーケティング - ファモチジン注射の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ファモチジン注射の産業動向 - ファモチジン注射のマーケットドライバー - ファモチジン注射の課題 - ファモチジン注射の阻害要因 ・主な調査結果 |
Famotidine injection is a colorless to yellowish clear liquid, and the indications are upper gastrointestinal bleeding caused by peptic ulcer, gastric and twelf Erosion and bleeding of intestinal mucosa.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Famotidine Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Famotidine Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Famotidine Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Famotidine Injection include Rakshit Drugs, Gauri Fine Chemicals, PAT IMPEX, Hainan Shuangcheng Pharmaceuticals, Hikma Pharmaceuticals, Baxter Healthcare, Athenex, Mylan Pharmaceuticals and Actiza Pharmaceutical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Famotidine Injection manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Famotidine Injection market. Further, it explains the major drivers and regional dynamics of the global Famotidine Injection market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Rakshit Drugs
Gauri Fine Chemicals
PAT IMPEX
Hainan Shuangcheng Pharmaceuticals
Hikma Pharmaceuticals
Baxter Healthcare
Athenex
Mylan Pharmaceuticals
Actiza Pharmaceutical
Omega Labs
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Famotidine Injection Segment by Type
10mg/mL
20mg/mL
Famotidine Injection Segment by Application
Hospital
Clinic
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Famotidine Injection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Famotidine Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Famotidine Injection, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Famotidine Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Famotidine Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Famotidine Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Famotidine Injection sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Rakshit Drugs, Gauri Fine Chemicals, PAT IMPEX, Hainan Shuangcheng Pharmaceuticals, Hikma Pharmaceuticals, Baxter Healthcare, Athenex, Mylan Pharmaceuticals and Actiza Pharmaceutical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Famotidine Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Famotidine Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Famotidine Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Famotidine Injection Product Introduction
1.2 Market by Type
1.2.1 Global Famotidine Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10mg/mL
1.2.3 20mg/mL
1.3 Market by Application
1.3.1 Global Famotidine Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Famotidine Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Famotidine Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Famotidine Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Famotidine Injection Sales by Region
2.4.1 Global Famotidine Injection Sales by Region (2017-2022)
2.4.2 Global Sales Famotidine Injection by Region (2023-2028)
2.5 Global Famotidine Injection Revenue by Region
2.5.1 Global Famotidine Injection Revenue by Region (2017-2022)
2.5.2 Global Famotidine Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Famotidine Injection Sales by Manufacturers
3.1.1 Global Top Famotidine Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Famotidine Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Famotidine Injection in 2021
3.2 Global Famotidine Injection Revenue by Manufacturers
3.2.1 Global Famotidine Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Famotidine Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Famotidine Injection Revenue in 2021
3.3 Global Famotidine Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Famotidine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Famotidine Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Famotidine Injection Sales by Type
4.1.1 Global Famotidine Injection Historical Sales by Type (2017-2022)
4.1.2 Global Famotidine Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Famotidine Injection Sales Market Share by Type (2017-2028)
4.2 Global Famotidine Injection Revenue by Type
4.2.1 Global Famotidine Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Famotidine Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Famotidine Injection Revenue Market Share by Type (2017-2028)
4.3 Global Famotidine Injection Price by Type
4.3.1 Global Famotidine Injection Price by Type (2017-2022)
4.3.2 Global Famotidine Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Famotidine Injection Sales by Application
5.1.1 Global Famotidine Injection Historical Sales by Application (2017-2022)
5.1.2 Global Famotidine Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Famotidine Injection Sales Market Share by Application (2017-2028)
5.2 Global Famotidine Injection Revenue by Application
5.2.1 Global Famotidine Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Famotidine Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Famotidine Injection Revenue Market Share by Application (2017-2028)
5.3 Global Famotidine Injection Price by Application
5.3.1 Global Famotidine Injection Price by Application (2017-2022)
5.3.2 Global Famotidine Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Famotidine Injection Market Size by Type
6.1.1 North America Famotidine Injection Sales by Type (2017-2028)
6.1.2 North America Famotidine Injection Revenue by Type (2017-2028)
6.2 North America Famotidine Injection Market Size by Application
6.2.1 North America Famotidine Injection Sales by Application (2017-2028)
6.2.2 North America Famotidine Injection Revenue by Application (2017-2028)
6.3 North America Famotidine Injection Market Size by Country
6.3.1 North America Famotidine Injection Sales by Country (2017-2028)
6.3.2 North America Famotidine Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Famotidine Injection Market Size by Type
7.1.1 Europe Famotidine Injection Sales by Type (2017-2028)
7.1.2 Europe Famotidine Injection Revenue by Type (2017-2028)
7.2 Europe Famotidine Injection Market Size by Application
7.2.1 Europe Famotidine Injection Sales by Application (2017-2028)
7.2.2 Europe Famotidine Injection Revenue by Application (2017-2028)
7.3 Europe Famotidine Injection Market Size by Country
7.3.1 Europe Famotidine Injection Sales by Country (2017-2028)
7.3.2 Europe Famotidine Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Famotidine Injection Market Size by Type
8.1.1 Asia Pacific Famotidine Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Famotidine Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Famotidine Injection Market Size by Application
8.2.1 Asia Pacific Famotidine Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Famotidine Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Famotidine Injection Market Size by Region
8.3.1 Asia Pacific Famotidine Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Famotidine Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Famotidine Injection Market Size by Type
9.1.1 Latin America Famotidine Injection Sales by Type (2017-2028)
9.1.2 Latin America Famotidine Injection Revenue by Type (2017-2028)
9.2 Latin America Famotidine Injection Market Size by Application
9.2.1 Latin America Famotidine Injection Sales by Application (2017-2028)
9.2.2 Latin America Famotidine Injection Revenue by Application (2017-2028)
9.3 Latin America Famotidine Injection Market Size by Country
9.3.1 Latin America Famotidine Injection Sales by Country (2017-2028)
9.3.2 Latin America Famotidine Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Famotidine Injection Market Size by Type
10.1.1 Middle East and Africa Famotidine Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Famotidine Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Famotidine Injection Market Size by Application
10.2.1 Middle East and Africa Famotidine Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Famotidine Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Famotidine Injection Market Size by Country
10.3.1 Middle East and Africa Famotidine Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Famotidine Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Rakshit Drugs
11.1.1 Rakshit Drugs Corporation Information
11.1.2 Rakshit Drugs Overview
11.1.3 Rakshit Drugs Famotidine Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Rakshit Drugs Famotidine Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Rakshit Drugs Recent Developments
11.2 Gauri Fine Chemicals
11.2.1 Gauri Fine Chemicals Corporation Information
11.2.2 Gauri Fine Chemicals Overview
11.2.3 Gauri Fine Chemicals Famotidine Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Gauri Fine Chemicals Famotidine Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Gauri Fine Chemicals Recent Developments
11.3 PAT IMPEX
11.3.1 PAT IMPEX Corporation Information
11.3.2 PAT IMPEX Overview
11.3.3 PAT IMPEX Famotidine Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 PAT IMPEX Famotidine Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 PAT IMPEX Recent Developments
11.4 Hainan Shuangcheng Pharmaceuticals
11.4.1 Hainan Shuangcheng Pharmaceuticals Corporation Information
11.4.2 Hainan Shuangcheng Pharmaceuticals Overview
11.4.3 Hainan Shuangcheng Pharmaceuticals Famotidine Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hainan Shuangcheng Pharmaceuticals Famotidine Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hainan Shuangcheng Pharmaceuticals Recent Developments
11.5 Hikma Pharmaceuticals
11.5.1 Hikma Pharmaceuticals Corporation Information
11.5.2 Hikma Pharmaceuticals Overview
11.5.3 Hikma Pharmaceuticals Famotidine Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hikma Pharmaceuticals Famotidine Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hikma Pharmaceuticals Recent Developments
11.6 Baxter Healthcare
11.6.1 Baxter Healthcare Corporation Information
11.6.2 Baxter Healthcare Overview
11.6.3 Baxter Healthcare Famotidine Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Baxter Healthcare Famotidine Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter Healthcare Recent Developments
11.7 Athenex
11.7.1 Athenex Corporation Information
11.7.2 Athenex Overview
11.7.3 Athenex Famotidine Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Athenex Famotidine Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Athenex Recent Developments
11.8 Mylan Pharmaceuticals
11.8.1 Mylan Pharmaceuticals Corporation Information
11.8.2 Mylan Pharmaceuticals Overview
11.8.3 Mylan Pharmaceuticals Famotidine Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mylan Pharmaceuticals Famotidine Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Pharmaceuticals Recent Developments
11.9 Actiza Pharmaceutical
11.9.1 Actiza Pharmaceutical Corporation Information
11.9.2 Actiza Pharmaceutical Overview
11.9.3 Actiza Pharmaceutical Famotidine Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Actiza Pharmaceutical Famotidine Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Actiza Pharmaceutical Recent Developments
11.10 Omega Labs
11.10.1 Omega Labs Corporation Information
11.10.2 Omega Labs Overview
11.10.3 Omega Labs Famotidine Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Omega Labs Famotidine Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Omega Labs Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Famotidine Injection Industry Chain Analysis
12.2 Famotidine Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Famotidine Injection Production Mode & Process
12.4 Famotidine Injection Sales and Marketing
12.4.1 Famotidine Injection Sales Channels
12.4.2 Famotidine Injection Distributors
12.5 Famotidine Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Famotidine Injection Industry Trends
13.2 Famotidine Injection Market Drivers
13.3 Famotidine Injection Market Challenges
13.4 Famotidine Injection Market Restraints
14 Key Findings in The Global Famotidine Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
| 【ファモチジン注射について】 ファモチジン注射（Famotidine Injection）は、胃酸分泌抑制剤の一種であり、主に胃腸関連の疾患において使用される医薬品です。ファモチジンは、ヒスタミンH2受容体拮抗薬（H2ブロッカー）に分類され、胃酸の分泌を抑えることにより、消化器系の不快な症状を緩和する作用があります。 ファモチジン注射は、経口投与が困難な患者に対して使用されることが一般的であり、例えば、手術後の患者や重篤な病状のある患者などが対象となります。注射剤は、速やかな効果を発揮するため、急性の症状に対する治療にも便利です。ファモチジンの作用機序としては、H2受容体に結合することによって、胃壁細胞からの酸分泌を抑制します。その結果、胃酸の量が減少し、胃炎や潰瘍の治癒を促進します。 ファモチジンの特徴としては、まずその効果の持続性が挙げられます。通常、単回投与で約10～12時間の効果が持続しますので、患者の状態に応じて適切な投与間隔を設定することが可能です。また、副作用が比較的少なく、他のH2ブロッカーに比べて安全性が高いとされています。具体的には、頭痛やめまい、下痢、便秘などの軽度の副作用が報告されていますが、重篤なアレルギー反応や肝機能障害のリスクは低いとされています。 ファモチジン注射にはさまざまな用途があります。主な用途としては、消化性潰瘍の治療や予防、胃食道逆流症（GERD）の症状緩和、ストレス潰瘍の予防などが挙げられます。また、手術前後の胃酸分泌の管理や、重症患者における胃腸の保護目的でも使用されることがあります。これらの疾患は、胃酸が過剰に分泌されることによって引き起こされるため、ファモチジンのようなH2ブロッカーが治療において重要な役割を果たします。 関連技術としては、ファモチジンの投与方法やその効果を最大限に引き出すための周辺技術が考えられます。例えば、注射剤としての調製技術や、薬剤の安定性を向上させるための製剤技術が挙げられます。特に注射剤においては、感染防止や投与の遊離状態での安定性を確保するための衛生管理や包装技術が重要です。また、患者のニーズに応じて、薬剤の持続的な効果を狙った持続放出製剤の開発も進められています。 ファモチジン注射は、他の薬剤との併用療法においても利用されます。例えば、抗生物質と組み合わせることで、Helicobacter pyloriによる胃潰瘍の治療効果を高めることが可能です。このように、ファモチジンは単独でも効果的ですが、他の薬剤と組み合わせることで、より良好な治療効果が期待されます。 ファモチジンの使用にあたっては、一定の注意点があります。妊婦や授乳中の女性における使用については、医師の判断が重要です。また、特定の基礎疾患を持つ患者や、肝臓や腎臓に障害のある患者においては、適切な用量調整が必要となります。これらの点を考慮し、医療従事者は患者一人一人の状態に応じた最適な治療を行うことが求められます。 ファモチジン注射は、医療現場で広く使用されている医薬品であるため、今後の研究や技術開発によってさらなる展望が期待されます。具体的には、新たな製剤形態の開発や、その他の消化器関連疾患に対する応用の可能性などが考えられています。ファモチジンは、医療の現場においては欠かせない存在であり、患者のQOL（Quality of Life）の向上にも寄与する重要な薬剤として、今後もその活用が進むことでしょう。 |